BIO-RAD LABORATORIES, INC. acquired DiaMed Benelux for 4.6 million Euros (approximately $5.6 million) in cash, a transaction completed in July 2012, structured as all cash.
DiaMed Benelux operates in Clinical Diagnostics, is based in Benelux (Belgium / Netherlands / Luxembourg). In July 2012, Bio-Rad acquired all of the outstanding shares of DiaMed Benelux, extending its DiaMed blood-typing diagnostics franchise in the Benelux region.
Clinical Diagnostics segment
In July 2012, we acquired all of the outstanding shares of DiaMed Benelux for 4.6 million Euros (approximately $5.6 million) in cash.Bio-Rad Laboratories FY2014 10-K, acquisitions disclosure
Advisory firms were not disclosed for this transaction.